BOZEMAN, Mont. & SANTA CLARA, Calif.--(BUSINESS WIRE)--Golden Helix, Inc., a global leader in genetic analysis software and services, and Agilent Technologies, Inc. (NYSE:A) today announced a relationship under which Golden Helix will provide researchers with software tools and services for Agilent’s copy number variation (CNV) microarrays. The goal is to empower Agilent CNV-based research with cutting-edge tools that accelerate and enhance large scale CNV association studies.
